Optimized AEX Buffer Formulations for AAV Full Capsid Enrichment

被引：0
|
作者：
Neufeld, Bella [1 ]
机构：
[1] Teknova, Res & Dev, Hollister, CA USA
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
429
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [41] Optimized sequential purification protocol for in vivo site-specific biotinylated full-length dengue virus capsid protein
    Chong, Mun Keat
    Parthasarathy, Krupakar
    Yeo, Hui Yu
    Ng, Mah Lee
    PROTEIN ENGINEERING DESIGN & SELECTION, 2013, 26 (05): : 377 - 387
  • [42] Full-Length Gene Enrichment by Using an Optimized RNA Isolation Protocol in Bixa orellana Recalcitrant Tissues
    Rodriguez-Avila, N. L.
    Narvaez-Zapata, J. A.
    Aguilar-Espinosa, M. L.
    Rivera-Madrid, R.
    MOLECULAR BIOTECHNOLOGY, 2009, 42 (01) : 84 - 90
  • [43] Full-Length Gene Enrichment by Using an Optimized RNA Isolation Protocol in Bixa orellana Recalcitrant Tissues
    N. L. Rodríguez-Ávila
    J. A. Narváez-Zapata
    M. L. Aguilar-Espinosa
    R. Rivera-Madrid
    Molecular Biotechnology, 2009, 42 : 84 - 90
  • [44] AAV Manufacturing Aims to Boost Productivity and Reduce Costs Industry players address issues such as the shift to suspension cultures, the need for capsid enrichment, and the selection of production platforms
    Labant M.
    Genetic Engineering and Biotechnology News, 2022, 43 (01): : 54and56and58 - 59
  • [45] Comparing CsCl Density Gradient Ultracentrifugation and Anion Exchange Chromatography for Full Capsid Enrichment of a Novel Adeno-Associated Viral Vector
    Facendola, Roberto
    Bodige, Kavitha
    Guzman, Jacob
    Carroll, Patrick
    Nguyen, Kevin
    Elich, Tom
    Sharma, Shamik
    Dhanasekharan, Kumar
    MOLECULAR THERAPY, 2024, 32 (04) : 499 - 499
  • [46] Angiotensin 1-7 Overexpression Mediated by a Capsid-optimized AAV8 Vector Leads to Significant Growth Inhibition of Hepatocellular Carcinoma In vivo
    Mao, Yingying
    Pei, Nana
    Chen, Xinglu
    Chen, Huiying
    Yan, Renhe
    Bai, Na
    Li, Andrew
    Li, Jinlong
    Zhang, Yanling
    Du, Hongyan
    Chen, Baihong
    Sumners, Colin
    Wang, Xuejun
    Wang, Shengqi
    Li, Hongwei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14 (01): : 57 - 68
  • [47] Mucopolysaccharidosis Type IIIB Disease Correction by Central Nervous System Delivery of a Modified AAV8 Capsid Expressing Codon Optimized NAGLU in a Mouse Model
    Heldermon, Coy
    Rouse, Courtney
    Hawkins, Kimberly
    Butterworth-Hosaka, Elizabeth
    Kim, Mi-Jung
    Dinelli, Isabella
    Kunta, Aishwarya
    Rosenkrantz, Erinn
    Kabbej, Nadia
    Dalugdug, Justin
    Falk, Darin
    MOLECULAR THERAPY, 2021, 29 (04) : 237 - 238
  • [48] Enhancing the production of adeno-associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design-of-experiment optimization of triple plasmid ratio
    Park, Sungje
    Shin, Seunghyeon
    Lee, Haeshin
    Jang, Jae-Hyung
    Lee, Gyun Min
    BIOTECHNOLOGY JOURNAL, 2024, 19 (03)
  • [49] An Optimized System for AAV Compatible Delivery of Full Length PCDH15 for Treatment of USH1F via RNA End Joining
    Williams, Claire E.
    Hsu, Ryan H.
    Hermann, Kip J.
    Bachmann, Lukas C.
    Pfaff, Samuel L.
    MOLECULAR THERAPY, 2024, 32 (04) : 760 - 760
  • [50] AAV-2 Production with Suspension HEK293 Cells in Scale-X Achieves High Productivity, High Full-to-Empty Capsid Ratio and Low Contaminants
    Cohen, Floriane
    MOLECULAR THERAPY, 2024, 32 (04) : 509 - 509
12345